Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses in the Wildermuth Fund to Contact Him Directly to Discuss Their OptionsIf you purchased or acquired securities in The Wildermuth Fund between November 1, 2020 and June 29, 2023 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information]New York, New York--(Newsfile ...

Core Viewpoint - Rosen Law Firm is encouraging investors of WPP plc who incurred losses exceeding $100,000 during the specified class period to secure legal counsel before the December 8, 2025 deadline for a securities class action lawsuit [1][2]. Group 1: Class Action Details - Investors who purchased WPP American Depositary Shares (ADS) between February 27, 2025, and July 8, 2025, may be eligible for compensation without any out-of-pocket fees through a contingency fee arrangement [2]. - A class action lawsuit has already been filed, and interested parties must move the Court to serve as lead plaintiff by December 8, 2025 [3]. - The Rosen Law Firm emphasizes the importance of selecting qualified counsel with a successful track record in securities class actions [4]. Group 2: Case Allegations - The complaint alleges that WPP's management provided overly positive statements while concealing material adverse facts about the company's media arm, which was reportedly unprepared for macroeconomic challenges and losing market share [5].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Sprouts Farmers Market, Inc. due to allegations of misleading statements regarding the company's growth potential and sales performance [2][5]. Group 1: Legal Investigation - The law firm is encouraging investors who suffered losses in Sprouts between June 4, 2025, and October 29, 2025, to discuss their legal options [1]. - A federal securities class action has been filed against Sprouts, with a deadline of January 26, 2026, for investors to seek the role of lead plaintiff [2][7]. - The firm has a history of recovering hundreds of millions of dollars for investors since its founding in 1995 [4]. Group 2: Allegations Against Sprouts - The complaint alleges that Sprouts and its executives violated federal securities laws by making false and misleading statements about the company's growth potential [5]. - It is claimed that the company provided overly positive statements while concealing material adverse facts, leading to shareholders purchasing securities at inflated prices [5]. Group 3: Financial Performance - On October 29, 2025, Sprouts reported a 4.3% decrease in comparable store growth compared to the previous quarter, which was below company projections [6]. - The company projected only 0%-2% growth in comp sales for the fourth quarter and reduced its full-year expectations from 7.5%-9% to 7% [6]. - Following the announcement, Sprouts' stock price fell by $22.64 to open at $81.91 per share [6].

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Alexandria Real Estate Equities, Inc. due to allegations of false and misleading statements regarding the company's Long Island City property and its financial performance [2][5]. Financial Performance - Alexandria reported third quarter earnings for 2025 that fell short of analyst expectations, with a 5% decline in revenue and a 7% decline in adjusted funds from operation [6]. - The average occupancy rate decreased from 94.8% in the previous year to 91.4% [6]. - Following the financial results announcement, Alexandria's stock price dropped over 19% on October 28, 2025 [6]. Legal Proceedings - A federal securities class action has been filed against Alexandria, with a deadline of January 26, 2026, for investors to seek the role of lead plaintiff [2][7]. - The complaint alleges that the company and its executives violated federal securities laws by making false statements and failing to disclose adverse facts about the company's property [5]. Investor Communication - Faruqi & Faruqi encourages investors who suffered losses in Alexandria to contact them directly to discuss legal options [1][8].

Core Viewpoint - A class action lawsuit has been filed against James Hardie Industries plc for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [2][4]. Group 1: Lawsuit Details - The lawsuit is pending in the U.S. District Court for the Northern District of Illinois, asserting claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors in James Hardie common stock [4]. - Investors have until December 23, 2025, to request to be appointed to lead the case [4]. Group 2: Company Performance and Allegations - James Hardie is known for producing high-performance fiber cement building solutions, primarily used in external siding for the residential building industry in the U.S. and Canada [5]. - During the relevant period, the company claimed strong performance in its North American fiber cement segment, but it is alleged that sales were inflated due to inventory loading by channel partners rather than genuine customer demand [6]. Group 3: Stock Impact - On August 19, 2025, James Hardie reported a 12% decline in North American fiber cement sales, leading to a stock price drop of $9.79 per share, or over 34%, from $28.43 to $18.64 [7].

Core Viewpoint - A lawsuit has been filed against MoonLake Immunotherapeutics and its senior executives for potential violations of federal securities laws, with a deadline for investors to join the case by December 15, 2025 [1][3]. Company Overview - MoonLake Immunotherapeutics is a clinical-stage biotechnology company focused on developing therapies for inflammatory diseases [4]. - The company conducted Phase 3 VELA trials for sonelokimab (SLK), aimed at treating moderate to severe hidradenitis suppurativa [4]. Allegations and Clinical Data - The lawsuit claims that MoonLake misrepresented its clinical data, asserting that SLK's Nanobody structure provided superior clinical benefits compared to competitors, which was allegedly not true [5][6]. - The company claimed strong clinical data from its Phase 2 MIRA trial, suggesting higher clinical responses and differentiation from competitors [5]. Stock Performance and Impact - Following the disappointing results from the VELA Phase 3 trials reported on September 28, 2025, MoonLake's stock price plummeted nearly 90%, from $61.99 to $6.24 per share [7].

Core Viewpoint - A class action lawsuit has been filed against Inspire Medical Systems, Inc. for securities fraud following a significant stock drop due to alleged violations of federal securities laws [2][4]. Company Overview - Inspire Medical Systems, Inc. develops and manufactures an implantable medical device for the treatment of sleep apnea, with the latest version being Inspire V, which received FDA approval on August 2, 2024 [5]. Allegations and Issues - The lawsuit claims that Inspire misled investors by assuring them that all necessary steps were taken for the launch of Inspire V, while in reality, the company failed to prepare clinicians and payors adequately, leading to delays in adoption [6][7]. - The company faced weak demand for Inspire V as many customers had excess inventory of older devices [7]. Stock Performance - On August 4, 2025, Inspire disclosed that the launch of Inspire V would take longer than expected, resulting in a reduction of its 2025 earnings per share guidance by over 80% [8]. - Following this announcement, Inspire's stock price dropped by $42.04 per share, or more than 32%, from $129.95 to $87.91 between August 4 and August 5, 2025 [9].

Core Viewpoint - A class action lawsuit has been filed against Freeport-McMoRan Inc. and certain senior executives for securities fraud, following significant stock drops attributed to potential violations of federal securities laws [2][4]. Company Overview - Freeport-McMoRan Inc. is a mining company with its Indonesian affiliate operating as PT Freeport Indonesia, which manages the Grasberg Copper and Gold Mine [5]. Allegations - The lawsuit alleges that Freeport overstated its commitment to safety, as unsafe mining practices at the Grasberg mine were likely to result in worker fatalities [6]. Stock Performance - On September 9, 2025, Freeport's stock dropped by $2.77 per share (over 5.9%) after announcing the suspension of mining operations due to a landslide that trapped team members [7]. - Following an update on September 24, 2025, indicating two fatalities and a projected 4% and 6% decrease in copper and gold sales respectively, the stock fell by $7.69 per share (almost 17%) [8]. - On September 25, 2025, further reports about strained relations with the Indonesian government led to an additional drop of $2.33 per share (over 6%) [10]. - An Indonesian news report on September 28, 2025, suggested that the landslide was preventable, further impacting investor confidence [11].

Core Viewpoint - A class action lawsuit has been filed against Synopsys, Inc. for securities fraud following a significant stock drop attributed to potential violations of federal securities laws [1][3]. Group 1: Lawsuit Details - Investors have until December 30, 2025, to request to lead the case in the U.S. District Court for the Northern District of California, under the caption Kim v. Synopsys, Inc., et al. [3] - The lawsuit asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of Synopsys investors [3]. Group 2: Company Performance - Synopsys provides design automation software products, with its Design IP segment being the fastest-growing, increasing from 25% of revenue in 2022 to 31% in 2024 [4]. - The company reported a revenue of $425.9 million for its Design IP segment in Q3 2025, reflecting a 7.7% year-over-year decline, and a net income of $242.5 million, down 43% year-over-year [6]. Group 3: Market Reaction - Following the release of Q3 2025 results, Synopsys stock fell nearly 36%, from $604.37 per share on September 9, 2025, to $387.78 per share on September 10, 2025, due to revelations about the need for increased customization from Design IP customers [6].

Core Viewpoint - A class action lawsuit has been filed against CarMax, Inc. for securities fraud following a significant drop in stock price due to alleged violations of federal securities laws [1][3]. Group 1: Lawsuit Details - Investors have until January 2, 2026, to request to lead the case in the U.S. District Court for the District of Maryland [3]. - The lawsuit claims violations under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 [3]. Group 2: Company Performance - CarMax reported disappointing financial results for Q2 of fiscal year 2026, with a 5.4% decline in retail used unit sales, a 6.3% decline in comparable store used unit sales, and a 2.2% decline in wholesale units [6]. - The net income for Q2 was approximately $95.4 million, down from $132.8 million in the previous year [6]. Group 3: Stock Price Impact - Following the financial results announcement on September 25, 2025, CarMax's stock price fell by $11.45 per share, or about 20%, from $57.05 to $45.60 [7]. - The unexpected departure of CEO Bill Nash on November 6, 2025, and a weak preliminary Q3 outlook led to an additional stock price drop of over 24% [7]. Group 4: Market Context - CarMax had previously promoted strong demand for its vehicles, which was allegedly inflated by a temporary surge in purchases before U.S. tariffs were imposed [4].